Key result
TAVI enables successful bloodless treatment of severe aortic stenosis in 2 Jehovah's Witness patients.
Why the study?
TAVI is reserved for high or prohibitive surgical-risk patients with aortic valve stenosis, but its use in Jehovah's Witness patients refusing blood products is not well documented.
Key points are not available for this paper at this time.
Population
Two Jehovah's Witness patients with symptomatic severe aortic valve stenosis
Design
Case report
May support TAVI feasibility in blood-refusing high-risk aortic stenosis patients; leaves open need for larger prospective studies.
Transcatheter aortic valve implantation (TAVI) is currently reserved for high or prohibitive surgical-risk patients with aortic valve stenosis. We report on successful TAVI in two Jehovah's witness patients. It offers a simple and effective treatment of severe aortic valve stenosis in high-risk patients who refuse the use of allogeneic blood and blood products.
No takes yet. Share an insight, caveat, or question.
Buz et al. (2012) studied this question. Transcatheter aortic valve implantation was successfully performed in two Jehovah's Witness patients, offering an effective treatment for severe aortic stenosis without the use of blood products.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: